These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 10710594)
1. Development and evaluation committees' methods for appraising new drugs. Committee failed to meet aims in producing report on low molecular weight heparins. Bosanquet N; Fox K BMJ; 2000 Mar; 320(7236):714-5. PubMed ID: 10710594 [No Abstract] [Full Text] [Related]
2. Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on. Antman EM Am Heart J; 2003 Aug; 146(2):191-3. PubMed ID: 12891179 [No Abstract] [Full Text] [Related]
3. [The role of low-molecular-weight heparin in unstable angina, acute myocardial infarction and post-elective percutaneous transluminal coronary angioplasty]. Pimentel Filho WA Arq Bras Cardiol; 1995 Dec; 65(6):517-8. PubMed ID: 8731307 [No Abstract] [Full Text] [Related]
4. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease. Krulewitz A N Engl J Med; 1998 Jan; 338(2):130; author reply 131. PubMed ID: 9424584 [No Abstract] [Full Text] [Related]
5. Low-molecular-weight heparins for the treatment of acute coronary syndromes. Wong GC; Giugliano RP Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446 [TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease. Goodall AH; Knight C N Engl J Med; 1998 Jan; 338(2):130-1. PubMed ID: 9424585 [No Abstract] [Full Text] [Related]
7. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
12. Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes. Rosito GA; Silva OB; Ribeiro JP Arq Bras Cardiol; 2001 Aug; 77(2):184-95. PubMed ID: 11514830 [No Abstract] [Full Text] [Related]
14. A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina. Malhotra S; Karan RS; Bhargava VK; Pandhi P; Grover A; Sharma YP; Kumar R Indian Heart J; 2001; 53(2):197-202. PubMed ID: 11428477 [TBL] [Abstract][Full Text] [Related]
15. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease. Husted S; Kher A Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983 [TBL] [Abstract][Full Text] [Related]
16. [The value of low-molecular-weight heparins in the treatment of acute coronary syndrome]. Carlsson J; Tebbe U Dtsch Med Wochenschr; 2002 Apr; 127(16):859-65. PubMed ID: 11961704 [No Abstract] [Full Text] [Related]